Wednesday, November 19, 2025 8:38:27 PM
Linda Powers’ personal jackpot: 180,723,564 potential shares
- 29.4 million common shares
- 57 million warrants
- 39.2 million options (2018 grant)
- 55.1 million options (2020 grant)
And her loyal inner circle (the rest of the named execs and directors) sit on another 81.7 million options and warrants.
That’s over 262 million fully-diluted shares controlled by management and their best buddies before a single new share is even printed.
Hey Linda, you greedy FCK, here’s a simple question the rest of us peasants would like answered BEFORE we rubber-stamp your 900-million-share authorized increase:
What exactly are you planning to do with all that new paper the minute the MHRA says yes?
How much are you raising?
At what price?
Who’s getting the sweetheart deals?
How many more tens of millions of nearly-free options are you and your cronies teeing up for yourselves the day DCVax-L gets approved?
Most of all, WTF is your plan and timeline with do this and that for the company growth?
Give us a real roadmap (pre-approval cash bridge + post-approval commercialization plan) and show us why 2.6 billion authorized shares are anything other than a blank check for you to loot what’s left of this company.
Do that, and a lot of us will grudgingly vote YES.
Keep hiding behind “we need flexibility” bullshit while you and your pals hold a quarter-billion potential shares… and it’s a hard FCK NO from every single one of us who had enough FCK from you.
My ~700k shares won’t swing the vote by themselves, but I’ll scream this from every rooftop until retail wakes up and sees the rigged game.
This proxy isn’t pre-determined until we let it be, or maybe you already know the result will be on your side.
Stop treating us like idiots or watch the NO votes pile up even if you win your SHT proxy on more bonuses and A/S increase to 2.7B.
FU LP. FU NWBO management. Transparency or GFYS/GTFO.
- 29.4 million common shares
- 57 million warrants
- 39.2 million options (2018 grant)
- 55.1 million options (2020 grant)
And her loyal inner circle (the rest of the named execs and directors) sit on another 81.7 million options and warrants.
That’s over 262 million fully-diluted shares controlled by management and their best buddies before a single new share is even printed.
Hey Linda, you greedy FCK, here’s a simple question the rest of us peasants would like answered BEFORE we rubber-stamp your 900-million-share authorized increase:
What exactly are you planning to do with all that new paper the minute the MHRA says yes?
How much are you raising?
At what price?
Who’s getting the sweetheart deals?
How many more tens of millions of nearly-free options are you and your cronies teeing up for yourselves the day DCVax-L gets approved?
Most of all, WTF is your plan and timeline with do this and that for the company growth?
Give us a real roadmap (pre-approval cash bridge + post-approval commercialization plan) and show us why 2.6 billion authorized shares are anything other than a blank check for you to loot what’s left of this company.
Do that, and a lot of us will grudgingly vote YES.
Keep hiding behind “we need flexibility” bullshit while you and your pals hold a quarter-billion potential shares… and it’s a hard FCK NO from every single one of us who had enough FCK from you.
My ~700k shares won’t swing the vote by themselves, but I’ll scream this from every rooftop until retail wakes up and sees the rigged game.
This proxy isn’t pre-determined until we let it be, or maybe you already know the result will be on your side.
Stop treating us like idiots or watch the NO votes pile up even if you win your SHT proxy on more bonuses and A/S increase to 2.7B.
FU LP. FU NWBO management. Transparency or GFYS/GTFO.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
